Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal

NCT04694612 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

676

Enrollment

OTHER_GOV

Sponsor class

Conditions

Covid19

Interventions

DRUG: Favipiravir
DRUG: Placebo
DRUG: Remdesivir

Sponsor

Nepal Health Research Council